Evidence map›Paper›PMID 35089403›Full record

ArticleVirchows Archiv : an international journal of pathology2022

The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.

Beatriz E Salazar, Tania Pérez-Cala, Sara Isabel Gomez-Villegas, Laura Cardona-Zapata, Sebastián Pazos-Bastidas, Alejandra Cardona-Estepa, Diego Enrique Vélez-Gómez, José Armando Justinico-Castro, Andrés Bernal-Cobo, Harold Adrián Dávila-Giraldo and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Diagnosing and grading gastric atrophy and intestinal metaplasia using semi-supervised deep learning on pathological images: development and validation study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Beatriz E SalazarBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia. beatriz.salazar@udea.edu.co.ORCID http://orcid.org/0000-0003-1108-015X
Tania Pérez-CalaBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0001-5095-3289
Sara Isabel Gomez-VillegasBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Laura Cardona-ZapataBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Sebastián Pazos-BastidasBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Alejandra Cardona-EstepaBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0001-5660-6405
Diego Enrique Vélez-GómezBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0002-6095-3706
José Armando Justinico-CastroDepartment of Pathology, School of Medicine, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0002-9368-8654
Andrés Bernal-CoboDepartment of Pathology, School of Medicine, University of Antioquia, Medellín, Colombia.
Harold Adrián Dávila-GiraldoDepartment of Pathology, School of Medicine, University of Antioquia, Medellín, Colombia.
Juan Carlos Benítez-GuerraBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Joaquín Tiberio Valencia-CárdenasIPS Universitaria, University of Antioquia, Medellín, Colombia.
Edgar de Jesús OspinaSomer Clinic, Rionegro, Colombia.
Rodrigo Castaño-LlanoCancer Institute, Las Americas Clinic, Medellín, Colombia.ORCID http://orcid.org/0000-0002-3392-6059
María Mercedes BravoCancer Biology Research Group, National Cancer Institute, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-6472-8362
Juan Carlos Cataño-CorreaInternal Medicine Infectious Disease Section, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0002-0150-5487
Jovanny ZabaletaDepartment of Integrative Oncology and Department of Pediatrics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Alba Alicia Trespalacios-RangelInfectious Disease Group, Department of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-7540-5868
Ana María Cock-BoteroCytology and Pathology Unit, Las Vegas Clinic, Medellín, Colombia.
Miguel Ignacio Roldán-PérezBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Alonso MartínezBacteria & Cancer Group, Department of Microbiology, School of Medicine, University of Antioquia, Medellín, Colombia.ORCID http://orcid.org/0000-0003-3619-6087
Universidad de Antioquia · COClínica Somer · COInstituto de Cancerología Las Américas · COInstituto Nacional de Cancerología · COLouisiana State University Health Sciences Center New Orleans · USPontificia Universidad Javeriana · CO

Funding

Ministerio de Ciencia, tecnología en Innovación (Minciencias) Colombia 617-2013Universidad de Antioquia 2014-1062
6 · The paper itself

Abstract

Stomach cancer (SC) incidence and mortality are relevant public health issues worldwide. In Colombia, screening for preneoplastic lesions (PNL) and the presence of H. pylori is not routinely performed. Therefore, the aim of this study was to evaluate OLGA-OLGIM staging and the interobserver agreement in gastritis and preneoplastic lesions in patients with gastroduodenal symptoms from Colombia. A cross-sectional study was conducted in 272 patients with gastroduodenal symptoms. Gastric biopsies were taken following the Updated Sydney System with the OLGA-OLGIM classification, and the results were evaluated by two pathologists. Chronic gastritis and PNL were reported in 76% and 24% of the patients, respectively. Furthermore, 25% of the patients with PNL displayed gastric atrophy (GA) and 75% intestinal metaplasia (IM). Agreement in the histopathological reading for IM was good, whereas for OLGA was variable, and for the H. pylori quantity was poor. OLGA-OLGIM stages 0-II were the most frequent (96%), while stage III (4%) and SC (4%) were the least frequent. Age and coffee consumption were associated with a higher prevalence of PNL. This work determined that 4% of the population is at high risk of developing SC and would benefit from follow-up studies. Reinforcement of training programs to improve the agreement in histopathology readings is required.

Indexed as

GastritisGastritis, AtrophicHelicobacter InfectionsHelicobacter pyloriPrecancerous ConditionsStomach NeoplasmsCross-Sectional StudiesHumansMetaplasiaObserver VariationRisk FactorsGastroduodenal diseasesHistopathologyOLGAOLGIM

Identifiers

PMID35089403
OpenAlexW4210241816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.